US 10077444
Compositions and methods for inhibiting expression of the LECT2 gene
granted A61PA61P1/16A61P13/12
Quick answer
US patent 10077444 (Compositions and methods for inhibiting expression of the LECT2 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 71
- CPC classes
- A61P, A61P1/16, A61P13/12